Megan van der Horst, PhD, was an associate from 2021 to 2022 at the Milken Institute Center for Strategic Philanthropy. She worked on the Center’s biomedical team, where she conducted research into ALS scientific and funding landscapes. Prior to joining the Milken Institute, van der Horst completed a PhD in bioanalytical chemistry at Vanderbilt University. Her dissertation research focused on developing diagnostic tests for infectious diseases and resulted in international
collaborations with physicians, scientists, and other stakeholders.